Angela Thedinga
Direktor/Vorstandsmitglied bei NKARTA, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Angela Thedinga
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NKARTA, INC. | Direktor/Vorstandsmitglied | 28.03.2022 | - |
| Independent Dir/Board Member | 28.03.2022 | - |
Karriereverlauf von Angela Thedinga
Ehemalige bekannte Positionen von Angela Thedinga
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.02.2020 | 01.10.2021 |
| Corporate Officer/Principal | 01.08.2019 | 25.02.2020 | |
| AVEXIS INC | Personalreferent | 01.07.2018 | 01.06.2019 |
Ausbildung von Angela Thedinga
| Massachusetts Institute of Technology | Graduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
| The University of North Carolina at Chapel Hill | Graduate Degree |
| University of Wisconsin | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Graduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Börse
- Insiders
- Angela Thedinga
- Erfahrung